<DOC>
	<DOC>NCT00517348</DOC>
	<brief_summary>To assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of IMA-026 administered subcutaneously (SC) or intravenously (IV) in healthy adults.</brief_summary>
	<brief_title>Study Evaluating IMA-026 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy men and women ages 18 50 Body weight greater than or equal to 50 kilograms Nonsmoker or fewer than 10 cigarettes per day No serious infection, i.e., requiring hospitalization or IV antibiotics, or an upper respiratory infection within 1 month before dosing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Adult</keyword>
</DOC>